Novel PET RANO BM 1.0 criteria: Regulatory perspectives on new endpoint definitions in brain metastases.
作者信息
Pignatti Francesco, Herold Ralf, Demolis Pierre, Rohr Ulrich-Peter
机构信息
The European Medicines Agency, Amsterdam, The Netherlands (F.P., R.H.).
Lyfjastofnun-Icelandic Medicines Agency, Reykjavik, Iceland (P.D.).
出版信息
Neuro Oncol. 2025 Jul 30;27(6):1407-1408. doi: 10.1093/neuonc/noaf067.
Abstract
摘要
相似文献
1
Novel PET RANO BM 1.0 criteria: Regulatory perspectives on new endpoint definitions in brain metastases.
Neuro Oncol. 2025 Jul 30;27(6):1407-1408. doi: 10.1093/neuonc/noaf067.
2
Response Assessment in Brain Metastases Managed by Stereotactic Radiosurgery: A Reappraisal of the RANO-BM Criteria.
Curr Oncol. 2023 Oct 24;30(11):9382-9391. doi: 10.3390/curroncol30110679.
3
Evaluation of the Effect of Radiosurgery for Target and Non-Target Lesions in Patients with Brain Metastases Using RANO-BM Criteria.
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241273324. doi: 10.1177/15330338241273324.
4
RANO criteria for response assessment of brain metastases based on amino acid PET imaging.
Nat Med. 2025 May;31(5):1424-1430. doi: 10.1038/s41591-025-03633-7. Epub 2025 May 8.
5
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments.
Neuro Oncol. 2025 Jan 12;27(1):77-88. doi: 10.1093/neuonc/noae208.
6
Development and routine implementation of deep learning algorithm for automatic brain metastases segmentation on MRI for RANO-BM criteria follow-up.
Neuroimage. 2025 Feb 1;306:121002. doi: 10.1016/j.neuroimage.2025.121002. Epub 2025 Jan 10.
7
Comparing available criteria for measuring brain metastasis response to immunotherapy.
J Neurooncol. 2017 May;132(3):479-485. doi: 10.1007/s11060-017-2398-8. Epub 2017 Mar 8.
8
Volumetric analysis: Rethinking brain metastases response assessment.
Neurooncol Adv. 2023 Dec 10;6(1):vdad161. doi: 10.1093/noajnl/vdad161. eCollection 2024 Jan-Dec.
9
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204.
J Clin Oncol. 2025 Apr;43(10):1210-1218. doi: 10.1200/JCO.24.00953. Epub 2025 Jan 3.
10
Effect of MRI-based semiautomatic size-assessment in cerebral metastases on the RANO-BM classification.
Clin Neuroradiol. 2020 Jun;30(2):263-270. doi: 10.1007/s00062-019-00785-1. Epub 2019 Jun 13.
本文引用的文献
1
RANO criteria for response assessment of brain metastases based on amino acid PET imaging.
Nat Med. 2025 May;31(5):1424-1430. doi: 10.1038/s41591-025-03633-7. Epub 2025 May 8.
2
Response assessment criteria for brain metastases: proposal from the RANO group.
Lancet Oncol. 2015 Jun;16(6):e270-8. doi: 10.1016/S1470-2045(15)70057-4. Epub 2015 May 27.
Zotero 插件